Lexington, KY – Today, TruDiagnostic announced the Dunedin Pace of Aging report is now available to all customers. This algorithm is part of an exclusive license agreement between TruDiagnostic and Duke University, previously available only for academic research.
- Pace of Aging is how quickly a person’s epigenetic markers are changing to hasten or slow their progression of biological aging, which is associated with many predictive health outcomes.
- This is the first customer-facing access to a test that determines a person’s epigenetic pace of aging with the DunedinPACE algorithm.
- DunedinPACE is more sensitive to short-term changes in aging than the standard methylation-based Biological Age algorithms currently available.
The DunedinPoAm report will be available as part of TruDiagnostic’s “TruAge” epigenetic biological age collection. Existing customers are also able to run previously submitted TruAge data through the DunedinPoAm algorithm for a historical look at their Pace of Aging.
Duke University is recognized as one of the nation’s leaders in biomedical research and engineering. The DunedinPACE exclusive license opens the door to more opportunities to validate and expand the use of this metric in advanced patient cohorts. Duke University and TruDiagnostic are currently collaborating on grant proposals to make this algorithm validated via other tissues as well.